Skip to main content

Table 3 Cosmetic outcomes according to Harvard Scale by (A) physician and (B) patients

From: IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study

Time point Cosmetic rating IOERT (125) EBRT (110) p value*
(A) Physician’s evaluation
 Before RT Excellent/good 96 (77%) 66 (60%) 0.01
Fair/Poor 29 (23%) 44 (40%)
 End RT Excellent/good 91 (73%) 62 (56%) 0.006
Fair/poor 34 (27%) 48 (44%)
 1 month after RT Excellent/good 99 (79%) 74 (67%) 0.03
Fair/poor 26 (21%) 36 (33%)
 6 months after RT Excellent/good 103 (82%) 78 (71%) 0.05
Fair/poor 22 (18%) 32 (29%)
 12 months after RT Excellent/good 104 (83%) 80 (73%) 0.08
Fair/poor 21 (17%) 30 (27%)
(B) Patients’ evaluation
 Before RT Excellent/good 81 (65%) 52 (47%) 0.006
Fair/poor 44 (35%) 58 (53%)
 End RT Excellent/good 78 (62%) 43 (39%) 0.0004
Fair/poor 47 (38%) 67 (61%)
 1 month after RT Excellent/good 91 (73%) 59 (54%) 0.001
Fair/poor 34 (27%) 51 (46%)
 6 months after RT Excellent/good 103 (82%) 73 (66%) 0.005
Fair/poor 22 (18%) 37 (34%)
 12 months after RT Excellent/good 105 (84%) 80 (73%) 0.04
Fair/poor 20 (16%) 30 (27%)
  1. *Chi-square test